4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-18-006819
President and CEO acquired 101,269 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brady Todd C President and CEO | 2018-03-06 | Grant or award | +101,269 | 302,483 | D | ||
| Derivatives | |||||||
| Brady Todd C President and CEO | 2018-03-06 | Grant or award · Employee Stock Option (Right to Buy) | +217,293 | 217,293 | D | ||
Loading xslF345X03/doc4.xml…